Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period.

[1]  J. Hoofnagle,et al.  Drug‐induced liver injury network (DILIN) , 2004, Hepatology.

[2]  P. Watkins,et al.  Liver transplantation for acute liver failure from drug induced liver injury in the United States , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[3]  F. D. de Abajo,et al.  Acute and clinically relevant drug-induced liver injury: a population based case-control study. , 2004, British journal of clinical pharmacology.

[4]  R. Andrade,et al.  HLA class II genotype influences the type of liver injury in drug‐induced idiosyncratic liver disease , 2004, Hepatology.

[5]  D. Juurlink.  Drug-induced hepatotoxicity. , 2003, The New England journal of medicine.

[6]  R. Andrade,et al.  Drug-induced hepatotoxicity , 2003, The New England journal of medicine.

[7]  William M. Lee,et al.  Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States , 2002, Annals of Internal Medicine.

[8]  X. Vidal,et al.  Prospective surveillance of acute serious liver disease unrelated to infectious, obstructive, or metabolic diseases: epidemiological and clinical features, and exposure to drugs. , 2002, Journal of hepatology.

[9]  P. Hillon,et al.  Incidence of drug‐induced hepatic injuries: A French population‐based study , 2002, Hepatology.

[10]  D. Larrey.  Epidemiology and Individual Susceptibility to Adverse Drug Reactions Affecting the Liver , 2002, Seminars in liver disease.

[11]  M. Lucena,et al.  Toxicidad hepática por fármacos. Dónde estamos y hacia dónde caminamos , 2002 .

[12]  C. Degott,et al.  Eotaxin expression and eosinophil infiltrate in the liver of patients with drug-induced liver disease. , 2001, Journal of hepatology.

[13]  C. Codina,et al.  The use of evidence in pharmacovigilance , 2001, European Journal of Clinical Pharmacology.

[14]  N. Kaplowitz.  Causality assessment versus guilt‐by‐association in drug hepatotoxicity , 2001, Hepatology.

[15]  R. Andrade,et al.  Comparison of two clinical scales for causality assessment in hepatotoxicity , 2001, Hepatology.

[16]  J H Lewis,et al.  Drug-induced liver disease. , 2000, Clinics in liver disease.

[17]  M. Rawlins,et al.  Accuracy of hepatic adverse drug reaction reporting in one English health region , 1999, BMJ.

[18]  R. Andrade,et al.  Case Report: Acute Liver Failure After Treatment with Nefazodone , 1999, Digestive Diseases and Sciences.

[19]  R. Andrade,et al.  Acute liver injury associated with the use of ebrotidine, a new H2-receptor antagonist. , 1999, Journal of hepatology.

[20]  C. Day,et al.  The natural history of histologically proved drug induced liver disease , 1999, Gut.

[21]  R. Victorino,et al.  Immunological investigation in hepatic drug reactions. , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[22]  R. Andrade,et al.  Hepatic Injury Caused by Acarbose , 1996, Annals of Internal Medicine.

[23]  L. Lasagna,et al.  Drug safety discontinuations in the United Kingdom, the United States, and Spain from 1974 through 1993: A regulatory perspective , 1995, Clinical pharmacology and therapeutics.

[24]  M. Lucena,et al.  Bentazepam-associated chronic liver disease , 1994, The Lancet.

[25]  L. G. García Rodríguez,et al.  Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors. , 1994, Archives of internal medicine.

[26]  G. Danan,et al.  Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. , 1993, Journal of clinical epidemiology.

[27]  H. Friis,et al.  Drug‐induced hepatic injury: an analysis of 1100 cases reported to The Danish Committee on Adverse Drug Reactions between 1978 and 1987 , 1992, Journal of internal medicine.

[28]  T. Almdal,et al.  Incidence of parenchymal liver diseases in Denmark, 1981 to 1985: Analysis of hospitalization registry data , 1991, Hepatology.

[29]  C. Bénichou.  Criteria of drug-induced liver disorders. Report of an international consensus meeting. , 1990, Journal of hepatology.

[30]  D. Cahalan.  Quantifying Alcohol Consumption: Patterns and Problems , 1981, Circulation.

[31]  M. Lucena,et al.  Hepatotoxicidad por tetrabamato. Presentación de 7 casos y revisión de la bibliografía , 2002 .

[32]  D. Larrey.  Drug-induced liver diseases. , 2000, Journal of hepatology.

[33]  B. H. Ch. Stricker,et al.  Drug-induced Hepatic Injury , 1985 .

[34]  H. Zimmerman,et al.  Hepatotoxicity: The adverse effects of drugs and other chemicals on the liver , 1978 .